UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024037
Receipt number R000027648
Scientific Title Universal screening for all newly diagnosed colorectal cancer patients to identify Lynch syndrome
Date of disclosure of the study information 2016/11/01
Last modified on 2019/03/20 07:43:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Universal screening for all newly diagnosed colorectal cancer patients to identify Lynch syndrome

Acronym

Universal screening to identify Lynch syndrome

Scientific Title

Universal screening for all newly diagnosed colorectal cancer patients to identify Lynch syndrome

Scientific Title:Acronym

Universal screening to identify Lynch syndrome

Region

Japan


Condition

Condition

Colorectal cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To identify Lynch syndrome patients who will be missed by the Amsterdam criteria or the revised Bethesda guidelines.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Rate of Lynch syndrome patients who meet the Amsterdam criteria and the Bethesda guidelines to all Lynch patients

Key secondary outcomes

Sensitivity of MSI and immunostaining to identify Lynch syndrome


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

95 years-old >=

Gender

Male and Female

Key inclusion criteria

Colorectal cancer patients treated at our hospital

Key exclusion criteria

Patients under 18 years old
Patients whose cancer tissue is not available for MSI analysis and immunostaining

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Kentaro
Middle name
Last name Yamashita

Organization

Sapporo Medical University

Division name

Department of Gastroenterology and Hepatology

Zip code

0608543

Address

S1W16, Chuo-ku, Sapporo

TEL

011-611-2111

Email

ykentaro@sapmed.ac.jp


Public contact

Name of contact person

1st name Kentaro
Middle name
Last name Yamashita

Organization

Sapporo Medical Universtiy

Division name

Department of Gastroeterology and Hepatology

Zip code

0608543

Address

S1W16, Chuo-ku, Sapporo

TEL

011-611-2111

Homepage URL


Email

ykentaro@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University

Institute

Department

Personal name



Funding Source

Organization

Sapporo Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo Medical University

Address

S1W16, Chuo-ku, Sapporo

Tel

0116112111

Email

ykentaro@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 08 Month 24 Day

Date of IRB

2016 Year 08 Month 24 Day

Anticipated trial start date

2017 Year 03 Month 01 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Other related information


Management information

Registered date

2016 Year 09 Month 13 Day

Last modified on

2019 Year 03 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027648